Skip to Main Content
Skip Nav Destination


Vorasidenib

Basics

Name

Vorasidenib

Pronunciation

(VOR a SID e nib)

Brand Names: US

  • Voranigo

Therapeutic Category

  • Antineoplastic Agent, IDH1 Inhibitor
  • Antineoplastic Agent, IDH2 Inhibitor

Medication Safety Issues

Sound-alike/look-alike issues:

Vorasidenib may be confused with enasidenib, ivosidenib, olutasidenib, vandetinib, vemurafenib, vismodegib, vorapaxar, vorinostat.

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal